Bradley Foster & Sargent’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-9,125
| Closed | -$906K | – | 371 |
|
|
2019
Q3 | $906K | Buy |
9,125
+451
| +5% | +$42.9K | 0.03% | 219 |
|
|
2019
Q2 | $802K | Sell |
8,674
-708
| -8% | -$67.2K | 0.03% | 228 |
|
|
2019
Q1 | $885K | Sell |
9,382
-9,281
| -50% | -$812K | 0.03% | 217 |
|
|
2018
Q4 | $1.2M | Sell |
18,663
-8,021
| -30% | -$592K | 0.05% | 189 |
|
|
2018
Q3 | $2.39M | Sell |
26,684
-4
| -0% | -$353 | 0.08% | 156 |
|
|
2018
Q2 | $2.12M | Sell |
26,688
-26,407
| -50% | -$2.19M | 0.08% | 164 |
|
|
2018
Q1 | $4.74M | Sell |
53,095
-4,924
| -8% | -$473K | 0.18% | 105 |
|
|
2017
Q4 | $6.05M | Sell |
58,019
-5,603
| -9% | -$632K | 0.22% | 97 |
|
|
2017
Q3 | $9.28M | Sell |
63,622
-52
| -0.1% | -$7.08K | 0.35% | 79 |
|
|
2017
Q2 | $8.27M | Sell |
63,674
-5,956
| -9% | -$730K | 0.33% | 80 |
|
|
2017
Q1 | $8.66M | Sell |
69,630
-3,126
| -4% | -$374K | 0.35% | 82 |
|
|
2016
Q4 | $8.42M | Buy |
72,756
+65
| +0.1% | +$7.24K | 0.36% | 81 |
|
|
2016
Q3 | $7.6M | Sell |
72,691
-1,412
| -2% | -$153K | 0.33% | 81 |
|
|
2016
Q2 | $7.31M | Sell |
74,103
-13,670
| -16% | -$1.41M | 0.33% | 82 |
|
|
2016
Q1 | $8.79M | Sell |
87,773
-12,273
| -12% | -$1.26M | 0.41% | 75 |
|
|
2015
Q4 | $12M | Sell |
100,046
-2,001
| -2% | -$232K | 0.55% | 63 |
|
|
2015
Q3 | $11M | Sell |
102,047
-1,105
| -1% | -$137K | 0.54% | 62 |
|
|
2015
Q2 | $11.9M | Buy |
103,152
+299
| +0.3% | +$34.2K | 0.54% | 67 |
|
|
2015
Q1 | $11.9M | Buy |
102,853
+15,130
| +17% | +$1.81M | 0.54% | 67 |
|
|
2014
Q4 | $9.81M | Buy |
87,723
+7,072
| +9% | +$746K | 0.46% | 76 |
|
|
2014
Q3 | $7.64M | Buy |
80,651
+7,472
| +10% | +$674K | 0.36% | 84 |
|
|
2014
Q2 | $6.29M | Buy |
73,179
+7,951
| +12% | +$605K | 0.31% | 93 |
|
|
2014
Q1 | $4.55M | Buy |
65,228
+13,634
| +26% | +$1.08M | 0.24% | 100 |
|
|
2013
Q4 | $4.36M | Buy |
51,594
+11,496
| +29% | +$910K | 0.23% | 105 |
|
|
2013
Q3 | $3.09M | Buy |
40,098
+12,148
| +43% | +$851K | 0.18% | 114 |
|
|
2013
Q2 | $1.64M | Buy |
+27,950
| New | +$1.68M | 0.1% | 133 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Bradley Foster & Sargent's CELG Position: Q4 2019 in Review
Bradley Foster & Sargent sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,125 shares — an estimated $906K sold.
Bradley Foster & Sargent first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $12M in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Bradley Foster & Sargent reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Bradley Foster & Sargent sold 9,125 Celgene Corp shares in Q4 2019, an estimated $906K.
- Bradley Foster & Sargent first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Bradley Foster & Sargent's Celgene Corp position peaked at $12M in Q4 2015.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Bradley Foster & Sargent's 13F filing for Q4 2019, filed 29 Jan 2020.